|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.749
|
Human |
|
|
negative regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0071930 |
2 |
0.680
|
Human |
|
|
dna conformation change
|
GO:0071103 |
113 |
0.614
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.599
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.591
|
Human |
|
|
chromatin modification
|
GO:0016568 |
298 |
0.565
|
|
|
|
regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0000083 |
8 |
0.524
|
Human |
|
|
female gamete generation
|
GO:0007292 |
2 |
0.349
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.301
|
Human |
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.279
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.277
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.259
|
Worm |
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.253
|
Human Mouse |
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.249
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.244
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.242
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.237
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.214
|
|
|
|
histone h3 k9 modification
|
GO:0061647 |
11 |
0.198
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.159
|
Human |
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.152
|
Human |
|
|
segmentation
|
GO:0035282 |
4 |
0.142
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.142
|
|
|
|
positive regulation of cell size
|
GO:0045793 |
3 |
0.138
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.126
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.119
|
Human |
|
|
macromolecule methylation
|
GO:0043414 |
97 |
0.118
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.118
|
|
|
|
mating
|
GO:0007618 |
1 |
0.115
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.114
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.112
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.110
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.106
|
Human |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.104
|
|
|
|
mrna stabilization
|
GO:0048255 |
18 |
0.104
|
Human |
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.102
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.101
|
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
41 |
0.099
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.099
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.097
|
Human |
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.094
|
Human |
|
|
immune system development
|
GO:0002520 |
195 |
0.092
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.091
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.090
|
Human |
|
|
fibroblast proliferation
|
GO:0048144 |
33 |
0.089
|
Human |
|
|
dna replication
|
GO:0006260 |
116 |
0.089
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.088
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.085
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.084
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.082
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.082
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.082
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.080
|
Human |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.078
|
|
|
|
patterning of blood vessels
|
GO:0001569 |
2 |
0.077
|
|
|
|
cartilage condensation
|
GO:0001502 |
1 |
0.076
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.076
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.076
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.074
|
Human |
|
|
immune response
|
GO:0006955 |
307 |
0.073
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.073
|
Human |
|
|
methylation
|
GO:0032259 |
106 |
0.072
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.072
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.070
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.070
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.069
|
|
|
|
protein acetylation
|
GO:0006473 |
116 |
0.068
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.068
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.067
|
|
|
|
histone methylation
|
GO:0016571 |
60 |
0.066
|
|
|
|
protein alkylation
|
GO:0008213 |
74 |
0.066
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.065
|
Human Mouse |
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.064
|
|
|
|
peptidyl threonine modification
|
GO:0018210 |
45 |
0.064
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.060
|
Human |
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.060
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.060
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
29 |
0.060
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.060
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.058
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.058
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.058
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.058
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.057
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.057
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.057
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.057
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.057
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.056
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.056
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.056
|
|
|
|
post embryonic hemopoiesis
|
GO:0035166 |
1 |
0.056
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.056
|
|
|
|
system process
|
GO:0003008 |
349 |
0.055
|
|
|
|
protein dna complex assembly
|
GO:0065004 |
64 |
0.055
|
|
|
|
regulation of dna replication
|
GO:0006275 |
68 |
0.055
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.055
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.054
|
Human Mouse |
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.054
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
80 |
0.053
|
|
|
|
double strand break repair
|
GO:0006302 |
101 |
0.052
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.052
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.052
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.051
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.051
|
|
|
|
specification of organ identity
|
GO:0010092 |
3 |
0.050
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.049
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.047
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.047
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.047
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.046
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.046
|
Worm |
|
|
dna packaging
|
GO:0006323 |
77 |
0.046
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.046
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.045
|
|
|
|
nucleosome organization
|
GO:0034728 |
66 |
0.045
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
71 |
0.044
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.044
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.043
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
57 |
0.043
|
|
|
|
rna stabilization
|
GO:0043489 |
18 |
0.042
|
Human |
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.042
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.041
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.041
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.041
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.040
|
Worm |
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.039
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.039
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.038
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.038
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.038
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.038
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.038
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.037
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
77 |
0.037
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.037
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.037
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.036
|
|
|
|
chromosome segregation
|
GO:0007059 |
114 |
0.036
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.036
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.035
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.035
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.035
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.035
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.035
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.035
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
1 |
0.035
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.034
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
78 |
0.034
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.034
|
|
|
|
post embryonic organ development
|
GO:0048569 |
1 |
0.034
|
Worm |
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.034
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.034
|
Human |
|
|
single organism nuclear import
|
GO:1902593 |
104 |
0.033
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.033
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.033
|
|
|
|
histone threonine phosphorylation
|
GO:0035405 |
7 |
0.032
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.032
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.032
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.032
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.031
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.031
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.031
|
|
|
|
positive regulation of proteasomal protein catabolic process
|
GO:1901800 |
35 |
0.031
|
|
|
|
positive regulation of dendrite morphogenesis
|
GO:0050775 |
3 |
0.031
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.031
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.031
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.031
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.031
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.030
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.030
|
|
|
|
prostate gland development
|
GO:0030850 |
3 |
0.030
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.030
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.030
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.030
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.029
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.029
|
|
|
|
mrna processing
|
GO:0006397 |
133 |
0.029
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.029
|
|
|
|
venous blood vessel development
|
GO:0060841 |
2 |
0.029
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.028
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.028
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.028
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.028
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.028
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.028
|
|
|
|
regulation of myoblast fusion
|
GO:1901739 |
1 |
0.028
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.028
|
|
|
|
dna replication dependent nucleosome assembly
|
GO:0006335 |
32 |
0.028
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.028
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.028
|
|
|
|
cilium assembly
|
GO:0042384 |
63 |
0.027
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.027
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.027
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.027
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.027
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.027
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.027
|
|
|
|
response to fungus
|
GO:0009620 |
4 |
0.027
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
56 |
0.027
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.027
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.026
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
44 |
0.026
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.026
|
|
|
|
negative regulation of smoothened signaling pathway
|
GO:0045879 |
3 |
0.026
|
|
|
|
neuroblast division
|
GO:0055057 |
1 |
0.026
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.026
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.026
|
|
|
|
histone acetylation
|
GO:0016573 |
93 |
0.026
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.025
|
|
|
|
myoblast differentiation
|
GO:0045445 |
21 |
0.025
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.025
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.025
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.025
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.025
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
3 |
0.024
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.024
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.024
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.024
|
|
|
|
protein methylation
|
GO:0006479 |
74 |
0.024
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.024
|
|
|
|
head development
|
GO:0060322 |
108 |
0.024
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.024
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.024
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.024
|
Human |
|
|
anoikis
|
GO:0043276 |
22 |
0.024
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.024
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.024
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.024
|
Human |
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.024
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.023
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
91 |
0.023
|
|
|
|
memory
|
GO:0007613 |
3 |
0.023
|
|
|
|
cellular response to nerve growth factor stimulus
|
GO:1990090 |
6 |
0.023
|
|
|
|
myoblast fusion
|
GO:0007520 |
1 |
0.023
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.023
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.023
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.023
|
Human |
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
43 |
0.023
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.023
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.023
|
|
|
|
mesenchymal to epithelial transition involved in metanephros morphogenesis
|
GO:0003337 |
4 |
0.023
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.023
|
Human |
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.023
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
40 |
0.022
|
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
26 |
0.022
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.022
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.022
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.022
|
|
|
|
male meiosis
|
GO:0007140 |
1 |
0.022
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.022
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.022
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.022
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.022
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.022
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
4 |
0.022
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.022
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.022
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.022
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
101 |
0.022
|
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
98 |
0.022
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
57 |
0.022
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.022
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.022
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.022
|
|
|
|
dna catabolic process
|
GO:0006308 |
49 |
0.022
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.022
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.022
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.022
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.021
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.021
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.021
|
|
|
|
regulation of mononuclear cell proliferation
|
GO:0032944 |
65 |
0.021
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.021
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.021
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.021
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.021
|
|
|
|
dna replication independent nucleosome organization
|
GO:0034724 |
27 |
0.021
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.021
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.021
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.021
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.021
|
|
|
|
dna duplex unwinding
|
GO:0032508 |
30 |
0.021
|
|
|
|
cell aggregation
|
GO:0098743 |
1 |
0.021
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.021
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.020
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
75 |
0.020
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.020
|
|
|
|
cell projection assembly
|
GO:0030031 |
126 |
0.020
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.020
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
32 |
0.020
|
Human |
|
|
renal system development
|
GO:0072001 |
63 |
0.020
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.020
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.020
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.020
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.020
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.020
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.020
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.020
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.020
|
|
|
|
nucleosome assembly
|
GO:0006334 |
50 |
0.020
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
67 |
0.020
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.020
|
|
|
|
cardiac chamber development
|
GO:0003205 |
30 |
0.019
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.019
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.019
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.019
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.019
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.019
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.019
|
|
|
|
antimicrobial humoral response
|
GO:0019730 |
26 |
0.019
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.019
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.019
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.019
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
73 |
0.019
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.019
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.018
|
|
|
|
neural tube patterning
|
GO:0021532 |
2 |
0.018
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.018
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.018
|
|
|
|
citrate metabolic process
|
GO:0006101 |
2 |
0.018
|
|
|
|
regulation of cellular ketone metabolic process by positive regulation of transcription from rna polymerase ii promoter
|
GO:0072366 |
1 |
0.018
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.018
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.018
|
|
|
|
epithelial cell development
|
GO:0002064 |
34 |
0.018
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.018
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.018
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.018
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
49 |
0.018
|
|
|
|
peptide transport
|
GO:0015833 |
74 |
0.018
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.018
|
|
|
|
dna replication dependent nucleosome organization
|
GO:0034723 |
32 |
0.018
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
51 |
0.018
|
|
|
|
dendrite development
|
GO:0016358 |
24 |
0.018
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.018
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
40 |
0.017
|
|
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
21 |
0.017
|
Human |
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.017
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.017
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
1 |
0.017
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.017
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
96 |
0.017
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.017
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.017
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.017
|
|
|
|
negative regulation of blood circulation
|
GO:1903523 |
4 |
0.017
|
|
|
|
multi organism reproductive process
|
GO:0044703 |
54 |
0.017
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.017
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.017
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.017
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.017
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.016
|
|
|
|
positive regulation of leukocyte activation
|
GO:0002696 |
80 |
0.016
|
|
|
|
visual behavior
|
GO:0007632 |
2 |
0.016
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.016
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.016
|
|
|
|
t cell homeostasis
|
GO:0043029 |
3 |
0.016
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.016
|
|
|
|
regulation of dendrite development
|
GO:0050773 |
18 |
0.016
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.016
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.016
|
|
|
|
actin filament organization
|
GO:0007015 |
128 |
0.016
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.016
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.016
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.016
|
|
|
|
adipose tissue development
|
GO:0060612 |
2 |
0.016
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.016
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.016
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.016
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.016
|
|
|
|
double strand break repair via homologous recombination
|
GO:0000724 |
50 |
0.016
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.015
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.015
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
45 |
0.015
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.015
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
101 |
0.015
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.015
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
4 |
0.015
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
4 |
0.015
|
|
|
|
neuronal stem cell division
|
GO:0036445 |
1 |
0.015
|
|
|
|
atp catabolic process
|
GO:0006200 |
157 |
0.015
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.015
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.015
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.015
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.015
|
|
|
|
translation
|
GO:0006412 |
132 |
0.015
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.015
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.015
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.015
|
|
|
|
protein deacetylation
|
GO:0006476 |
38 |
0.015
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
4 |
0.015
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.015
|
|
|
|
positive regulation of meiotic cell cycle
|
GO:0051446 |
2 |
0.015
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.015
|
|
|
|
dna replication independent nucleosome assembly
|
GO:0006336 |
27 |
0.015
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.015
|
|
|
|
positive regulation of t helper cell differentiation
|
GO:0045624 |
2 |
0.015
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.015
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.015
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.015
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.015
|
Mouse |
|
|
negative regulation of axonogenesis
|
GO:0050771 |
4 |
0.015
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
119 |
0.015
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.015
|
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
3 |
0.015
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.014
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
29 |
0.014
|
|
|
|
protein deacylation
|
GO:0035601 |
39 |
0.014
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.014
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.014
|
|
|
|
histone h3 k79 methylation
|
GO:0034729 |
2 |
0.014
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.014
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.014
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.014
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.014
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
4 |
0.014
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.014
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.014
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.014
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
4 |
0.014
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.014
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.014
|
|
|
|
positive regulation of cell cycle arrest
|
GO:0071158 |
23 |
0.014
|
|
|
|
recombinational repair
|
GO:0000725 |
50 |
0.014
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.014
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.014
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.014
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.014
|
|
|
|
sex differentiation
|
GO:0007548 |
45 |
0.014
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.014
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.014
|
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
71 |
0.014
|
|
|
|
embryonic digestive tract morphogenesis
|
GO:0048557 |
2 |
0.014
|
|
|
|
negative regulation of response to dna damage stimulus
|
GO:2001021 |
33 |
0.014
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
54 |
0.014
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
42 |
0.014
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.014
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.013
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
81 |
0.013
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.013
|
|
|
|
dna recombination
|
GO:0006310 |
77 |
0.013
|
|
|
|
notch signaling pathway
|
GO:0007219 |
31 |
0.013
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.013
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.013
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.013
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.013
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.013
|
|
|
|
regulation of dendrite morphogenesis
|
GO:0048814 |
11 |
0.013
|
|
|
|
negative regulation of dna metabolic process
|
GO:0051053 |
57 |
0.013
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.013
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
75 |
0.013
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.013
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.013
|
|
|
|
regulation of double strand break repair via homologous recombination
|
GO:0010569 |
11 |
0.013
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.013
|
|
|
|
rostrocaudal neural tube patterning
|
GO:0021903 |
1 |
0.013
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.013
|
|
|
|
regionalization
|
GO:0003002 |
29 |
0.013
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.013
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.013
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.013
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.013
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.013
|
|
|
|
negative regulation of phosphatase activity
|
GO:0010923 |
61 |
0.013
|
|
|
|
humoral immune response
|
GO:0006959 |
49 |
0.013
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
64 |
0.013
|
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.013
|
Human |
|
|
endocytosis
|
GO:0006897 |
159 |
0.013
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
3 |
0.013
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.013
|
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
2 |
0.013
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.013
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.013
|
|
|
|
epidermis development
|
GO:0008544 |
59 |
0.013
|
|
|
|
positive regulation of mitosis
|
GO:0045840 |
25 |
0.013
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.013
|
|
|
|
histone ubiquitination
|
GO:0016574 |
31 |
0.013
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.013
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.013
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.013
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
1 |
0.013
|
|
|
|
reproduction
|
GO:0000003 |
63 |
0.013
|
|
